Latest NewsSep 25, 2025HiFiBiO Therapeutics to Present Updated Phase 1 Clinical Data of Two Immuno-Oncology Programs at the 2025 Annual Meeting of the European Society for Medical Oncology (ESMO) All Filter By: Year20252024202320222021202020192018201720162015Mar 30, 2020Droplet Microfluidic Screening and Sequencing Can Vastly Expand the Universe of New Antibody TherapeuticsJan 11, 2020Biotechs Build on Single-cell Analytics for Drug R&D, as Human Cell Atlas is MappedOct 28, 2019HiFiBiO Therapeutics Establishes World-Class Scientific Advisory BoardAug 28, 2019HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune DisordersJun 3, 2019HiFiBiO Therapeutics and Leading Academic Institutions Demonstrate Breakthrough Single-Cell Approach for Novel Biomarker Discovery to Combat Cancer< 1 … 11 12 13 14 15 … 18 >
